Neogenomics (NEO) Total Debt Growth (3y) (2013 - 2020)
Neogenomics (NEO) Total Debt Growth (3y) (2013 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 5.73% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 10.14% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -4.73% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 7.07% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 5.11% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -60.49% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -12.66% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -0.64% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 9.58% |
| 10 | Neogenomics | 2.05 Bn | 1.90 Bn | 91.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 6.93% |
| Dec 31, 2019 | 9.43% |
| Sep 30, 2019 | 23.39% |
| Jun 30, 2019 | 23.35% |
| Mar 31, 2019 | 18.99% |
| Dec 31, 2018 | 16.14% |
| Sep 30, 2017 | 139.18% |
| Jun 30, 2017 | 231.23% |
| Mar 31, 2017 | 152.39% |
| Dec 31, 2016 | 113.66% |
| Sep 30, 2016 | 168.30% |
| Dec 31, 2015 | 93.34% |
| Sep 30, 2014 | 5.24% |
| Jun 30, 2014 | -19.54% |
| Dec 31, 2013 | 30.08% |